Reports for ATHENA PHARMACEUTIQUES SAS
Company Name
ATHENA PHARMACEUTIQUES SAS
Totals |
||
Shortage reports |
4 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 4 (100%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
2 (50%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATHENA-ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-12-05 | 2022-05-19 | 68662 |
| ATHENA-ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-12-05 | 2022-05-19 | 68659 |
| ATHENA-ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-13 | 2017-11-27 | 29122 |
| ATHENA-ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-15 | 2017-09-07 | 10326 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0